SAGGAR RAJEEV (Chief Medical Officer) sold 35.9% of their position (79.53K shares) of LIQUIDIA CORP on the open market
Open‑market sale worth $5.97M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/19/2026ACC: 0001104659-26-098862
Officer· Chief Medical Officer
Since Jul 2022
-79.53K
Net shares
Net seller
$5.97M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
50K acquired · 129.53K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−29.53K
Price / share
$76.84
Trade value
$2.27M
% of position
17.2%
8/17/2026
171.80K→142.26K
Common Stock
Direct
Shares
+50K
Price / share
$3.73
Trade value
$186.50K
% of position
35.1%
8/19/2026
142.26K→192.26K
Common Stock
Direct
Shares
−50K
Price / share
$74.06
Trade value
$3.70M
% of position
26.0%
8/19/2026
192.26K→142.26K
Total
Net shares
−29.53K
Net value
-$5.79M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2026 | S · Sale | −29.53K | $76.84 | $2.27M | 17.2% | 171.80K | 142.26K |
| Common Stock Direct | 8/19/2026 | M · Option Exercise | +50K | $3.73 | $186.50K | 35.1% | 142.26K | 192.26K |
| Common Stock Direct | 8/19/2026 | S · Sale | −50K | $74.06 | $3.70M | 26.0% | 192.26K | 142.26K |
| Total | −29.53K | -$5.79M | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
3.73
Held after
150K
Exercisable
—
8/19/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock50K shares | 8/19/2026 | M · Option Exercise | −50K | 3.73 | — | 150K |